Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Clinical trial NCT01244230 · COMPLETED

Trial details

NCT number: NCT01244230
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2010-11-01
Primary completion: 2011-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.